Cargando…

LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism

Colorectal cancer (CRC) is a highly malignant tumor associated with poor prognosis, yet the molecular mechanisms are not fully understood. In this study, we showed that LYAR, a nucleolar protein, is expressed at a higher level in CRC tissue than in adjacent normal tissue and that LYAR expression is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yupeng, Zhou, Yu, Gao, Haiying, Wang, Yajun, Cheng, Qingyu, Jian, Shikun, Ding, Qi, Gu, Wei, Yao, Yanxue, Ma, Jia, Wu, Wenjuan, Li, Yuyun, Tong, Xuhui, Song, Xiaoyuan, Ma, Sai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769847/ https://www.ncbi.nlm.nih.gov/pubmed/35069968 http://dx.doi.org/10.1155/2021/9979707

Ejemplares similares

LYAR promotes colorectal cancer cell mobility by activating galectin-1 expression
por: Wu, Yupeng, et al.
Publicado: (2015)

Human fetal globin gene expression is regulated by LYAR
por: Ju, Junyi, et al.
Publicado: (2014)

The Nucleolar Protein LYAR Facilitates Ribonucleoprotein Assembly of Influenza A Virus
por: Yang, Cha, et al.
Publicado: (2018)

Up-regulation of LYAR blocks Myc-induced cell death
por: Qiu, Shenglong, et al.
Publicado: (2017)

Prognostic significance of FSCN family in multiple myeloma
por: Deng, Cong, et al.
Publicado: (2021)

Significance of BMI1 and FSCN1 Expression in Colorectal Cancer
por: Alajez, Nehad M.
Publicado: (2016)

SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
por: Xiao, Weikai, et al.
Publicado: (2020)

Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer
por: Ou, Chunlin, et al.
Publicado: (2019)

miR-145 Contributes to the Progression of Cervical Carcinoma by Directly Regulating FSCN1
por: Ma, Li, et al.
Publicado: (2019)

LINC00355 promoted the progression of lung squamous cell carcinoma through regulating the miR-466/LYAR axis
por: Sun, XueFeng, et al.
Publicado: (2020)

LYAR potentiates rRNA synthesis by recruiting BRD2/4 and the MYST-type acetyltransferase KAT7 to rDNA
por: Izumikawa, Keiichi, et al.
Publicado: (2019)

Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients
por: Liang, Jiayu, et al.
Publicado: (2019)

FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017)

FSCN-1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition
por: Zhang, Yuanbiao, et al.
Publicado: (2018)

Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
por: Bai, Wen, et al.
Publicado: (2023)

MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1
por: Li, Ying-Qing, et al.
Publicado: (2015)

RGL2 as an age-dependent factor regulates colon cancer progression
por: Cheng, Qingyu, et al.
Publicado: (2021)

FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration
por: Li, Sisi, et al.
Publicado: (2021)

FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
por: Li, Minghui, et al.
Publicado: (2022)

The role of microRNA-133b and its target gene FSCN1 in gastric cancer
por: Guo, Lihua, et al.
Publicado: (2014)

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017)

miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion
por: Liu, Yanping, et al.
Publicado: (2017)

1,8 Cineole and Ellagic acid inhibit hepatocarcinogenesis via upregulation of MiR-122 and suppression of TGF-β1, FSCN1, Vimentin, VEGF, and MMP-9
por: Abdallah, Heba M. I., et al.
Publicado: (2022)

MicroRNA-488 inhibits proliferation and motility of tumor cells via downregulating FSCN1, modulated by Notch3 in breast carcinomas
por: Wu, Yang, et al.
Publicado: (2020)

Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion
por: Chen, Jia-jia, et al.
Publicado: (2015)

miR-429 functions as a tumor suppressor by targeting FSCN1 in gastric cancer cells
por: Zhang, Min, et al.
Publicado: (2016)

Fscn1 is required for the trafficking of TGF-β family type I receptors during endoderm formation
por: Liu, Zhaoting, et al.
Publicado: (2016)

Correction to: The role of microRNA-133b and its target gene FSCN1 in gastric cancer
por: Guo, Lihua, et al.
Publicado: (2020)

Transcriptome analysis reveals the potential biological function of FSCN1 in HeLa cervical cancer cells
por: Guo, Fengqin, et al.
Publicado: (2022)

Comprehensive analysis of the expression, prognosis and biological significance of FSCN family in clear cell renal cell carcinoma
por: Lin, Yongping, et al.
Publicado: (2023)

LncRNA PTOV1-AS2 Promotes Colon Cancer Progression through the miR-145-5p/FSCN1 Axis
por: Zhang, Zhen, et al.
Publicado: (2023)

SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion
por: Li, Zean, et al.
Publicado: (2023)

Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1
por: Gao, Wei, et al.
Publicado: (2019)

PDS5B inhibits cell proliferation, migration, and invasion via upregulation of LATS1 in lung cancer cells
por: Xu, Hui, et al.
Publicado: (2021)

FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance
por: Li, Zhongxun, et al.
Publicado: (2022)

FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2019)

GRHL3 activates FSCN1 to relax cell-cell adhesions between migrating keratinocytes during wound reepithelialization
por: Kashgari, Ghaidaa, et al.
Publicado: (2021)

LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1
por: Shang, Muhe, et al.
Publicado: (2018)

FSCN1 Promotes Esophageal Carcinoma Progression Through Downregulating PTK6 via its RNA-Binding Protein Effect
por: Cai, Hongfei, et al.
Publicado: (2022)

Retracted: FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p3lbs8bnp9g4fhejfvs1qvuq1d